摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

cleomiscosin A methyl ether

中文名称
——
中文别名
——
英文名称
cleomiscosin A methyl ether
英文别名
(2R,3R)-3-(3,4-dimethoxyphenyl)-2-(hydroxymethyl)-5-methoxy-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one
cleomiscosin A methyl ether化学式
CAS
——
化学式
C21H20O8
mdl
——
分子量
400.385
InChiKey
YJINBIPHZOTKQM-SJLPKXTDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    29
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    92.7
  • 氢给体数:
    1
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    cleomiscosin A methyl etherN-溴代丁二酰亚胺(NBS) 作用下, 以 氯仿 为溶剂, 反应 2.0h, 以67%的产率得到5-bromocleomiscosin A methyl ester
    参考文献:
    名称:
    Synthesis and anti-inflammatory activity of derivatives of coumarino-lignoid, cleomiscosin A and its methyl ether
    摘要:
    Six novel cleomiscosin A (a coumarino-lignoid), derivatives have been synthesized for the first time by using electrophilic substitution reaction to give nuclear nitrated and halogenated derivatives of cleomiscosin A in good yields. Structures of these compounds were established on the basis of IR, H-1 NMR, C-13 NMR and Mass spectral data. Some of the synthesized derivatives were tested for in-vitro target based anti-inflammatory study using primary macrophages cell culture bioassay system. The results showed that the compounds 1a, 3a and 4a (1 and 10 mu g/mL) exhibited potent anti-inflammatory activity. (C) 2010 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2010.08.027
  • 作为产物:
    描述:
    重氮甲烷6-methoxy-5′′-demethoxydaphneticin甲醇乙醚 为溶剂, 反应 24.0h, 以13 mg的产率得到cleomiscosin A methyl ether
    参考文献:
    名称:
    Study of anti-inflammatory, analgesic and antipyretic activities of seeds of Hyoscyamus niger and isolation of a new coumarinolignan
    摘要:
    A chemical and biological validation of the traditional use of Hyoscyamus niger seeds as anti-inflammatory drug has been established The methanolic extract of seeds of H niger (MHN) was evaluated for its analgesic, anti-inflammatory and antipyretic activities in experimental animal models at different doses MHN produced significant increase in hot plate reaction time, while decreasing writhing response in a close-dependent manner indicating its analgesic activity It was also effective in both acute and chronic inflammation evaluated through carrageenin-induced paw oedema and cotton pellet granuloma methods In addition to its analgesic and anti-inflammatory activity, it also exhibited antipyretic activity in yeast-induced pyrexia model Furthermore, the bioactive MHN tinder chemical investigation showed the presence of coumarinolignans as major chemical constituent and yielded a new coumarinolignan, cleomiscosin A methyl ether (1) along with four known coumarinolignans, cleomiscosin A (2), cleomiscosin B (3), cleomiscosin A-9'-acetate (4) and cleomiscosin B-9'-acetate (5) The structure elucidation of 1 was done by spectroscopic data interpretation and comparative HPLC analysis Cleomiscosin A, but not its isomer cleomiscosin B, reduced dry and wet weight of cotton pellet granuloma in mice This suggests that cleomiscosin A is all important constituent of MHN responsible for anti-inflammatory activity (C) 2009 Elsevier B V All rights reserved
    DOI:
    10.1016/j.fitote.2009.08.024
点击查看最新优质反应信息

文献信息

  • QSAR, docking and in vitro studies for anti-inflammatory activity of cleomiscosin A methyl ether derivatives
    作者:Shelly Sharma、Sunil Kumar Chattopadhyay、Dharmendra Kumar Yadav、Feroz Khan、Shilpa Mohanty、Anil Maurya、Dnyaneshwar Umrao Bawankule
    DOI:10.1016/j.ejps.2012.09.008
    日期:2012.12
    A series of five (6a-8b) novel polyhalogenated derivatives and an interesting ester (9a) derivative have been synthesized from cleomiscosin A methyl ether. All the six derivatives were subjected to in silico QSAR modeling and docking studies and later the predicted results were confirmed through in vitro experiments. QSAR modeling results showed that compounds 6a and 9a possessed anti-inflammatory activity comparable or even higher than diclofenac sodium. Docking results revealed that compounds 9a and 6a showed very good anti-inflammatory activity due to low docking energies of viz., IL6 (-92.45 and -81.993 kcal mol(-1)), TNF-alpha (-94.992 and -69.235 kcal mol(-1)) and IL1 beta (-67.462 and -65.985 kcal mol(-1)). Further all the six novel derivatives were subjected for in vitro anti-inflammatory activity using primary macrophages cell culture bioassay system. At the initial doses of 1 mu g/ml and 10 mu g/ml, the pro-inflammatory cytokines (IL-1 beta, IL-6 and TNF-alpha) were quantified from cell culture supernatant using enzyme linked immunosorbent assay (ELISA). The in vitro effect of 6a-9a on cell viability in mouse peritoneal macrophage cells isolated from mice was evaluated using MTT assay. The in silico and in vitro data suggested that all the derivatives might be considered as potential anti-inflammatory drug-like molecules. (C) 2012 Elsevier B.V. All rights reserved.
查看更多

同类化合物

黄花菜木脂素B 瑞香替西 (2S,3S)-daphneticin repenin D cleomiscosin A methyl ether ethyl 3,9-dihydro-3-(4-hydroxy-3-methoxyphenyl)-7-methyl-9-oxo-2H-[1,4]dioxino[2,3-h] chromene-2-carboxylate repenin B ethyl 3,9-dihydro-3-(3,4-dihydroxyphenyl)-7-methyl-9-oxo-2H-[1,4]dioxino[2,3-h]chromene-2-carboxylate repenin C moluccanin molucannin diacetate 8'-epi-cleomiscosin A cleomiscosin A (2S,3S)-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-5-methoxy-9H-[1,4]dioxino[2,3-h]chromen-9-one Cleomiscosin D cleomiscosin A monoacetate cleomiscosin D hyosgerin (7′R,8′R)-cleomiscosin C cleomiscosin A diacetate isodaphneticin (3R)-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-5-methoxy-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one 5'-Demethylaquillochin (2R,3R)-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-2,3-dihydropyrano[3,2-g][1,4]benzodioxin-7-one cis regioisomer of proparcin regioisoner of proparcin propacin compound-B cleomiscosin A daphneticin cleomiscosin A 6-methoxy-5′′-demethoxydaphneticin [4-[2-(Hydroxymethyl)-5-methoxy-9-oxo-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-3-yl]-2-methoxyphenyl] 3-phenylprop-2-enoate 2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-7H-pyrano[2,3-g][1,4]benzodioxin-7-one 2-(Hydroxymethyl)-3-[3-methoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one Cleomiscosin A methyl ether 3-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(8-oxo-[1,3]dioxolo[4,5-h]chromen-2-yl)-2H-pyrano[3,2-h][1,4]benzodioxin-9-one 6-Chloro-3-(4-hydroxy-3-methoxyphenyl)-5-methoxy-2-methyl-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one 2-[3,5-Dimethoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-(hydroxymethyl)-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one Cleomiscosin B [3-(4-Hydroxy-3,5-dimethoxyphenyl)-5-methoxy-9-oxo-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-2-yl]methyl 3,4-dihydroxybenzoate aquillochin methyl ether 2-(3-Hydroxy-4-methoxyphenyl)-3-methyl-2,3-dihydropyrano[2,3-g][1,4]benzodioxin-7-one 2-(3,4-Dihydroxy-5-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydropyrano[2,3-g][1,4]benzodioxin-7-one [3-(3,4-Dimethoxyphenyl)-5-methoxy-9-oxo-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-2-yl]methyl acetate 3-[3,5-Dimethoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2-(hydroxymethyl)-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one [3-(4-Hydroxy-3,5-dimethoxyphenyl)-5-methoxy-9-oxo-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-2-yl]methyl acetate [2-Methoxy-4-(5-methoxy-2-methyl-9-oxo-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-3-yl)phenyl] acetate 3-(4-Hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one [3-(4-Hydroxy-3-methoxyphenyl)-5-methoxy-9-oxo-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-2-yl]methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate